Cancer is a significant health concern throughout the globe and a leading
cause of death. In this review, we provide the summary of global incidences,
causes and future trend of cancer incidences in subcontinent region from
2015 to 2035, based on population data driven by World health organization
(GLOBOCAN) online prediction calculator. Data on the estimated number of
new cancer cases, mortality rate and global prevalence is available on GLOBOCAN
for all the countries and regions of the world. Data from the Cancer
facts and figures by World Cancer Research Fund International and Worldwide
Cancer Statistics by Cancer Research UK is also utilized. GLOBOCAN
provide global data on 27 different cancer types except nonmelanoma dermal
cancer. It shows data for both genders at all age groups. Demographic
effect of projected cancer incidences in subcontinent in both genders
has been compared with global demographic effect which predicted an
expected constant rise in all the years projected from 2015 to 2035. Cancer
friendly behaviors and cancer causing factors in the world are expected to
increase the global economic burden due to growth and aging of population.
A collective response from all the sectors of society will be helpful to design
and implement a coordinated and integrated comprehensive program to
control the rapidly growing burden of cancer in subcontinent.
Cancer cases, death rates, incidence, mortality, survival, demographic
effect, disability-adjusted life year
Novel silver glycinate conjugate with 3D polymeric intermolecular self-assembly architecture; an antiproliferative agent which induces apoptosis on human breast cancer cells.
Banti CN, Raptopoulou CP, Psycharis V, Hadjikakou SK
Journal of inorganic biochemistry. 2021; 216(): 111351
Two-year effectiveness and safety of golimumab in ulcerative colitis: An IG-IBD study.
Pugliese D, Privitera G, Rogai F, Variola A, Viola A, Laterza L, Privitera AC, Allocca M, Bossa F, Cappello M, Daperno M, Lorenzon G, Mazzuoli S, Principi M, Sablich R, Moser L, Ferronato A, Traini S, Tapete G, Bodini G, Di Girolamo M, Grossi L, Mocci G, Ricci C, Saibeni S, Festa S, Spagnuolo R, Cortelezzi CC, Mocciaro F, Rizzello F, Armuzzi A,
United European gastroenterology journal. 2021; 9(1): 102-109
Combining multiple decedent data sources for a population-based picture of end-of-life health care utilization.
Ma J, Beliveau J, Snider W, Jordan W, Casarett D
Journal of pain and symptom management. 2021; ():
T2 gallbladder cancer shows substantial survival variation between continents and this is not due to histopathologic criteria or pathologic sampling differences.
DeSimone MS, Goodman M, Pehlivanoglu B, Memis B, Balci S, Roa JC, Jang KT, Jang JY, Hong SM, Lee K, Kim H, Choi HJ, Muraki T, Araya JC, Bellolio E, Sarmiento JM, Maithel SK, Losada HF, Basturk O, Reid MD, Koshiol J, Adsay V
Virchows Archiv : an international journal of pathology. 2021; ():
Effect of Growth Regulators on Micropropagation of Potato ( L.) Gudiene and Belete Varieties from Ethiopia.
Hajare ST, Chauhan NM, Kassa G
TheScientificWorldJournal. 2021; 2021(): 5928769
New Acetophenones and Chromenes from the Leaves of A. Gray.
Le KT, Bandolik JJ, Kassack MU, Wood KR, Paetzold C, Appelhans MS, Passreiter CM
Molecules (Basel, Switzerland). 2021; 26(3):
Is phase angle a valuable prognostic tool in cancer patients' survival? A systematic review and meta-analysis of available literature.
Arab A, Karimi E, Vingrys K, Shirani F
Clinical nutrition (Edinburgh, Scotland). 2021; ():
Recurrence and survival after standard versus oncoplastic breast-conserving surgery for breast cancer.
AndrĂ© C, Holsti C, Svenner A, Sackey H, Oikonomou I, Appelgren M, Johansson ALV, de Boniface J
BJS open. 2021; 5(1):